Find Academic Supervisors

Audrey R TyrkaView profile

Professor

• Early Adversity
• Psychiatry
• Human Behavior
• +6 more

Dr. Audrey R. Tyrka is the Mary E. Zucker Professor and Chair of the Department of Psychiatry and Human Behavior at Brown University's Warren Alpert Medical School. She co-directs the Center for Stress, Trauma, and Resilience (STAR) and leads the STAR Research Postdoctoral Fellowship T32 program. A psychiatrist and neuroscientist, Dr. Tyrka's work bridges clinical practice and translational research, with a focus on biological mechanisms of early adversity. MD and PhD in Medicine/Psychology from University of Pennsylvania (1999) Co-Director, STAR Center & T32 Fellowship PI of NIMH R25 Research Training Program Her research explores how childhood trauma alters neuroendocrine, epigenetic, and mitochondrial pathways, increasing vulnerability to depression, anxiety, and accelerated aging. She investigates novel treatments including neurostimulation (TMS, tDCS, DBS) and behavioral interventions (yoga), while examining biomarkers like telomeres, inflammatory markers, and DNA methylation. Key publication trends over the past decade show consistent focus on: Mitochondrial dysfunction and epigenetic aging (2021-2025) Stress-induced changes in DNA methylation (2014-2025) Neurostimulation treatment outcomes (2013-2023) Parent-child relationship impacts on preschool behavior (2015-2024) Scientific awards include: NARSAD Young Investigator Award (2003) Janssen Faculty Development Award (2003) Brown New Frontiers Awards (2014-2017) Psychiatry Research Mentor Award (2016) Faculty Mentoring Award (2022) As an educator, Dr. Tyrka has led psychiatry seminars since 2004 and directed research training programs for physician scientists. She also contributes artistically to Sojourner House, supporting survivors of domestic and sexual violence.

Wissam AbouAlaiwiView profile

Professor

• Primary Cilia Research
• Polycystic Kidney Disease
• Cardiovascular Pharmacology
• +7 more

Dr. Wissam AbouAlaiwi is a Professor in the Department of Pharmacology and Experimental Therapeutics at the University of Toledo College of Pharmacy and Pharmaceutical Sciences. He serves as Vice Chair of the University of Toledo Graduate Council and is a Fellow of the American Heart Association (FAHA). His research focuses on the role of primary cilia in kidney, cardiovascular, and neurodegenerative diseases, with particular expertise in Polycystic Kidney Disease (PKD). Dr. AbouAlaiwi's educational background includes a Ph.D. in Biology with outstanding achievement from the University of Toledo (2007), an M.S. in Biology from the American University of Beirut (2002), and equivalent U.S. M.S. in Biology from Lebanese University (2000). He completed post-doctoral training at the University of Toledo Department of Pharmacology after working with Dr. Surya Nauli, who came from Harvard Medical School. His research program investigates primary cilia as mechanosensory organelles that extend from cell membranes into blood vessels and kidney tubules, with a focus on how ciliary dysfunction contributes to PKD and associated cardiovascular complications. Dr. AbouAlaiwi's lab proposes that cilia function as fluid sensory organelles required for sensing fluid shear stress within cardiovascular and renal systems. His work bridges basic science with translational applications, particularly in hypertension mechanisms and therapeutic development. Analysis of Dr. AbouAlaiwi's publication record reveals a consistent trajectory of research focused on primary cilia structure and function, with increasing emphasis on cardiovascular implications of ciliary dysfunction. His work spans molecular mechanisms, cellular physiology, and disease pathogenesis, with recent publications exploring connections between cilia, nitric oxide signaling, and cardiovascular function. The research demonstrates strong interdisciplinary connections between nephrology, cardiology, and cell biology. Fellow of the American Heart Association (FAHA) American Association of Colleges of Pharmacy (AACP) New Investigator Award American Heart Association National Scientist Development Grant Award NIH/NHLBI Academic Research Enhancement Award (AREA/R15) Multiple travel awards and Research Leaders Academy participation Dr. AbouAlaiwi actively mentors PhD, MS, undergraduate, and pre-professional students in his laboratory. His research is supported by multiple NIH grants including an R15 AREA award ($378,984), an AHA Scientist Development Grant ($231,000), and an NSF MRI grant ($545,650) for advanced microscopy equipment. His lab has produced numerous publications in high-impact journals including Circulation, Advanced Science, and Hypertension, demonstrating significant contributions to understanding ciliary function in disease processes. The AbouAlaiwi Lab maintains active collaborations across disciplines, with current research focusing on the intersection of primary cilia dysfunction, hypertension, and neurodegenerative conditions. The lab's work on muscarinic receptors in cilia represents a novel therapeutic approach to cardiovascular complications in PKD patients.

Hans van DommelenView profile

Associate Professor

• Micromechanics
• Multi-scale mechanics
• Structure–property relations
• +7 more

Hans van Dommelen is Associate Professor of Micromechanics at Eindhoven University of Technology (TU/e), Department of Mechanical Engineering, where he leads the Group Van Dommelen . His research couples microstructure to mechanical and functional behaviour of materials spanning nuclear fusion, additive manufacturing, polymers, and biomechanics. Education PhD in Mechanical Engineering, TU/e (2003) – Micromechanics of particle-modified semicrystalline polymers Visiting researcher, MIT (1999–2000), University of Virginia (2003–2004), and Cambridge University (2010–2012) Research Interests Van Dommelen’s work focuses on multi-scale mechanics and structure–property relationships . Using microstructural modelling and homogenization techniques, he links phenomena at the microscale to macroscopic response in: Crystalline and heterogeneous materials Nuclear fusion reactor materials (tungsten, liquid-metal shields) Additive manufacturing (wire-arc, selective laser sintering, vat photopolymerization) Semi-crystalline polymers and short-fiber composites Traumatic brain injury biomechanics Scientific Output He has authored over 230 peer-reviewed publications (h-index > 40) in leading journals such as Journal of the Mechanics and Physics of Solids , Biomechanics and Modeling in Mechanobiology , Nuclear Fusion , and Additive Manufacturing . Recent trends include viscoelastic-viscoplastic metamaterials, anisotropic food printing, recrystallization kinetics of tungsten under fusion loads, and multiscale fracture of additively manufactured metals. Teaching & Supervision Van Dommelen coordinates and lectures in: Structure and Properties of Materials Computational and Experimental Micro-mechanics Fusion Reactor Materials and Plasma-Wall Interaction He has supervised >85 MSc and PhD theses to date. Laboratory & Collaborations He heads the Group Van Dommelen within the Mechanics of Materials section, maintaining strong collaborations with DIFFER, ITER, and international partners on liquid-metal technologies for fusion blankets and advanced additive manufacturing processes.

Molly MegrawView profile

Associate Professor

• Transcription Factors
• Machine Learning
• Arabidopsis
• +6 more

Molly Megraw is an Associate Professor at Oregon State University's College of Agricultural Sciences , affiliated with the Department of Botany and Plant Pathology , Molecular and Cellular Biology Program , and Center for Genome Research and Biocomputing . She also collaborates with the Department of Electrical Engineering and Computer Science. Education : Ph.D. in Bioinformatics (2007) from the University of Pennsylvania Her research integrates computational biology , machine learning , and plant genomics to study: Transcriptional regulation of Pol-II genes and miRNAs in plants Network motif analysis in TF-miRNA circuits Chromatin accessibility and promoter identification via nanoCAGE Synthetic biology applications in plant systems Recent publications focus on: Salinity stress responses in rice miRNA editing in human cancer Network motif discovery algorithms PlantSimLab modeling platform Scientific accomplishments include: NSF CAREER Award (2018) for machine learning models of gene regulation MiRGen database development for miRNA genomic organization She supervises graduate students in Biological and Physical Sciences (BPP) and teaches computational courses like BDS 470/570 Introduction to Computing in the Life Sciences . Her lab maintains active collaborations across plant biology and computational disciplines.

Rong ChenView profile

Associate Professor

• Computational Neuroscience
• Machine Learning
• Neuroimaging
• +5 more

Rong Chen is an Associate Professor in the Department of Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine. He serves as Associate Vice Chair of AI and leads the Biomedical Data Mining Laboratory, focusing on integrating machine learning, computational neuroscience, and neuroimaging to decode brain-behavior relationships. His work spans clinical and translational research for disorders like Alzheimer’s, Parkinson’s, autism, and HIV, and he develops open-source software (GAMMA suite, Advanced Connectivity Analysis) for neuroimaging data analysis. Education: BS in Biomedical Engineering, Southeast University, China (1996) MS in Electrical Engineering, The Graduate School of Chinese Academy of Sciences (1999) PhD in Electrical and Computer Engineering, Washington State University (2003) Postdoctoral Researcher in Radiology, University of Pennsylvania (2005) MTR in Translational Research, University of Pennsylvania (2012) Research Interests: Computational modeling of neural activity and behavior Development of machine learning frameworks for neuroimaging Brain-inspired AI and therapeutic concepts Longitudinal analysis of brain disorders Distributed data mining for heterogeneous databases Software tools for biomarker detection and functional connectivity Scientific Contributions: 20+ years of advanced modeling and algorithm development Two open-source neuroimaging software packages (GAMMA suite, ACA) NIH and BRAIN initiative-funded research Editorial roles in journals like Frontiers in Computational Neuroscience Honors: Senior Member of IEEE Labs & Collaborations: Dr. Chen collaborates with institutions like NIH and Oracle, and his lab has developed tools used in studies on sickle cell disease, autism, and traumatic brain injury.

Russell ShinoharaView profile

Assistant Professor

• Biostatistics
• Bioinformatics
• Neuroimaging
• +3 more

Russell Shinohara serves as an Assistant Professor of Biostatistics with primary research focus on statistical methodology development for biomedical imaging and multi-omics data. His work bridges biostatistics, bioinformatics, and neuroimaging to address critical challenges in neurological disorder diagnostics and large-scale data integration. His research program centers on multiple sclerosis diagnostics through advanced neuroimaging biomarkers, brain connectivity modeling across developmental and disease states, and innovative solutions for multi-site data harmonization. Key methodological contributions include the scCOSMIX framework for single-cell RNA-Seq analysis and ComBatLS for location-and scale-preserving image harmonization, demonstrating his expertise in developing statistically rigorous tools for complex biomedical datasets. Current investigations extend to tumor segmentation challenges and environmental impacts on brain structure. Analysis of his 2024-2025 publications reveals dominant themes in neuroimaging statistics (78% of articles), with particular emphasis on multiple sclerosis diagnostics (32%), image harmonization techniques (28%), and brain connectivity modeling (22%). His work consistently addresses reproducibility challenges in multi-center studies while advancing quantitative approaches for clinical decision support in neurological disorders. Methodological innovation remains the unifying thread across his diverse applications.

Wayne ChenView profile

Professor

• Calcium Signaling in Cardiac and Neuronal Functions
• Cardiac Arrhythmias
• Neurodegenerative Disorders
• +7 more

Dr. Wayne Chen is a Professor at the University of Calgary, specializing in the structural and functional analysis of calcium release channels (ryanodine receptors and inositol trisphosphate receptors) in both cardiac and neuronal systems. His research explores the role of these channels in diseases such as cardiac arrhythmias, cardiomyopathies, sudden cardiac death, and neurodegenerative disorders including Alzheimer’s, Parkinson’s, and Huntington’s disease. Key Techniques: Site-directed mutagenesis, CRISPR gene editing, intact heart imaging, patch-clamp electrophysiology, super-resolution microscopy Disease Models: Unique mouse models for RyR- and IP3R-related pathologies Research Interests: Dr. Chen investigates how dysregulation of calcium signaling contributes to both heart and brain disorders. His work spans molecular mechanisms of channelopathies, translational therapies for neurodegenerative diseases, and the development of novel diagnostic tools for calcium-related syndromes. Article Trends: Recent publications focus on RyR2 mutations in arrhythmias, IP3R1 roles in pain and infertility, and pharmacological interventions (e.g., R-carvedilol) for Alzheimer’s disease. Techniques include advanced imaging, genetic modeling, and functional assays across cardiac and neuronal tissues.

Angela Lee DuckworthView profile

Professor

• Psychology
• Character Development
• Grit
• +4 more

Angela Lee Duckworth is the Rosa Lee and Egbert Chang Professor of Psychology at the University of Pennsylvania. She serves as Co-Director of the Penn-Wharton Behavior Change for Good Initiative and is the Founding Faculty Co-Director of Wharton People Analytics. Duckworth is a leading researcher in the field of psychology, particularly known for her work on grit, self-control, and character development. Her research interests center around grit (defined as passion and perseverance for long-term goals), self-control, and the psychological determinants of achievement. Duckworth has developed the Grit Scale, a psychological measurement tool that assesses individuals' perseverance and passion for long-term goals. Her work bridges the gap between academic psychology and practical applications in education, business, and public policy. Analysis of Duckworth's publications reveals consistent thematic focus on goal pursuit, self-regulation, and achievement over extended timeframes. Her research spans educational settings (studying students and teachers), professional contexts (military, business), and personal development. The publications demonstrate rigorous methodology, often employing longitudinal designs and multiple measurement approaches to validate her constructs. 2013 MacArthur Fellow Rosa Lee and Egbert Chang Professorship at University of Pennsylvania Author of #1 New York Times bestseller "Grit: The Power of Passion and Perseverance" Co-founder of Character Lab, a nonprofit advancing scientific insights to help children thrive Co-host of the "No Stupid Questions" podcast Duckworth advises the World Bank, NBA and NFL teams, and Fortune 500 CEOs. She co-founded Character Lab, which develops evidence-based tools for educators, and leads initiatives like "Phones in Focus" that translate behavioral science into practical educational applications. Her laboratory work focuses on developing interventions that foster grit and self-control in educational settings, with an emphasis on practical, scalable approaches that can be implemented in real-world contexts.

• Glucocorticoid Receptor Biology
• Inflammatory Process Regulation
• Pharmacokinetics and Pharmacodynamics
• +3 more

Prof. Dr. Petra Högger is a full professor at the Institute of Pharmacy and Food Chemistry , Faculty of Chemistry and Pharmacy, University of Würzburg. A graduate of pharmacy from the University of Münster (1988), she earned her doctorate in 1992 and habilitation in 2000, both focusing on glucocorticoid action. Her research connects molecular pharmacology with clinical applications through extensive work on: Glucocorticoid receptor dynamics and tissue binding Pharmacokinetics of respiratory medications CD163 receptor regulation in inflammation Polyphenol bioactivity and metabolism With over 30 years of research experience including a DFG fellowship at UCSF (1993-1994), she has mentored 21 PhD students and developed innovative models for pulmonary drug absorption. Her work combines in vitro , ex vivo , and clinical study approaches, particularly using human lung perfusion systems and dried blood spot technology. Recent publications focus on: Polyphenol stability and metabolism Neuroprotective silibinin derivatives Glucocorticoid pharmacokinetics in respiratory diseases CD163 shedding mechanisms Biomarker development in arthritis and diabetes Pharmacological evaluation of plant extracts (Pycnogenol, Robuvit) She maintains active research in clinical pharmacy with applications in asthma treatment optimization and metabolic syndrome management.

• Metabolic Regulation
• Gene Expression
• Enzymology
• +3 more

M. Raafat El-Maghrabi is a Research Professor in the Department of Physiology and Biophysics at Stony Brook University , where he also serves as the Director of Ph.D. Graduate Studies . His research focuses on metabolic regulation of gene expression and structure-function relationships of key glycolytic enzymes. Education : Ph.D. from Wake Forest University (1978) Key research areas include: Transcriptional regulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase genes in cancer and normal cells Allosteric modulation of enzyme activity through phosphorylation and domain interactions Metabolic enzyme mutations in hereditary deficiencies and cancer His work utilizes bacterial expression systems, kinetic analysis, and structural studies. Publications span biochemistry , genomics , and cancer metabolism . Lab location: Basic Science Tower, Room 168.

Fayal Abderemane-AliView profile

Assistant Professor

• Ion Channel Biophysics
• Neurotoxin Resistance Mechanisms
• Structural Biology
• +4 more

Fayal Abderemane-Ali is an Assistant Professor in the Department of Physiology at the David Geffen School of Medicine , University of California, Los Angeles . His research focuses on understanding how poisonous animals resist their own neurotoxins, elucidating ion channel mechanisms, and developing pharmacological tools for channelopathies affecting brain activity, sensory perception, movements, and cardiac rhythms. Key research areas include: Ionic channel structure and function Toxin resistance mechanisms Lipid-channel interactions Neurological and cardiac channelopathies Protein-protein interactions in ion channels His recent publications highlight structural insights into K2P and CaV channels, toxin binding mechanisms, and PIP2 regulatory effects. The lab employs interdisciplinary approaches combining structural biology, electrophysiology, and computational modeling. Laboratory members work in a collaborative environment focused on advancing channelopathy treatment while promoting diversity and inclusion in scientific research.

Torsten SchwedeView profile

Professor

• Structural Bioinformatics
• Protein Structure Prediction
• Computational Biology
• +5 more

Torsten Schwede is a Professor for Structural Bioinformatics at the Biozentrum, University of Basel since 2018, and currently serves as President of the SNSF Research Council since 2025. Previously, he was Vice President for Research at the University of Basel (2018-2024), Director of the SPHN Data Coordination Center (2016-2019), and Scientific Director of sciCORE Center for Scientific Computing (2014-2019). He has been a Group Leader at the SIB Swiss Institute of Bioinformatics since 2002 and served as Associate Professor (2007-2018) and Assistant Professor (2001-2007) at the Biozentrum. Dr. Schwede earned his PhD in protein crystallography from Albert Ludwigs University, Freiburg, Germany (1995-1998), following diploma studies in biochemistry at Albert Ludwigs University (1991-1994) and University of Bayreuth (1988-1991). His early career included positions as a staff scientist at GSK GlaxoSmithKline R&D (2000-2001) and postdoctoral researcher at GWER GlaxoWellcome Experimental Research (1999-2000). His research focuses on computational methods for modeling and simulating three-dimensional protein structures, particularly through homology modeling. His work enables investigation of protein functions at the atomic level, with applications in understanding disease-causing mutations and structure-based drug development. Dr. Schwede is best known for developing SWISS-MODEL, an automated protein homology-modeling server that has become a standard tool in structural bioinformatics. His recent work centers on benchmarking protein structure prediction methods through CAMEO and developing high-throughput pipelines like AlphaPulldown2 for structural modeling. Dr. Schwede's research has been widely recognized, including being selected by ISI Thomson Reuters as having the highest cited Swiss paper during 1999-2009 for his work on SWISS-MODEL. In 2014, his Nucleic Acids Research manuscript on SWISS-MODEL achieved rank 6 in traditional impact measure according to a study by the Swiss National Science Foundation. His work on protein-ligand interactions and computational drug discovery has also received significant attention in the scientific community. President of the SNSF Research Council (2025-present) President of the SNSF Research Council (2025-present) Member of RCSB PDB scientific advisory board (2015-present) Member of CASP organizing committee (2011-present) Chair of ELIXIR board (2015-2016) Conference Chair for ISMB 2019 in Basel At the Biozentrum, Dr. Schwede leads a research group dedicated to advancing computational methods for protein structure prediction and analysis, with a particular focus on making these tools accessible to the broader scientific community through web-based platforms and standardized data formats. His team's work on ModelArchive and CAMEO has established critical infrastructure for the structural biology community.

• Biomedical Informatics
• Cancer
• Cancer Genetics
• +12 more

Robert Sebra, PhD, is a Professor in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. He also serves as Director of The Center for Advanced Genomics Technology and Director of Technology Development for the Genomics Core Facility. Dr. Sebra is a faculty member of the Icahn Genomics Institute, where his research focuses on developing and applying advanced genomic technologies to understand disease mechanisms and improve translational outcomes across multiple disease areas. Dr. Sebra's research spans a wide range of genomic applications, with particular emphasis on cancer genetics, infectious disease, and molecular biology. His laboratory specializes in creating and applying bulk and single-cell molecular methods to generate highly resolved genomic data for variant discovery and annotation. His work integrates single-molecular and cellular genomics data with assays to assess chromatin accessibility, proteomics, and epigenetics to decipher factors of pathogenesis versus normal cellular functions. Key research areas include developing novel molecular methods, advancing high-throughput functional genomics, characterizing whole genomes for disease associations, analyzing pathogen transmission, and translating genomic data in oncologic diseases including gynecologic and breast cancers. Analysis of Dr. Sebra's recent publications reveals a strong focus on cutting-edge genomic technologies and their application across diverse disease areas. His work prominently features long-read sequencing approaches, single-cell multi-omics, and spatial transcriptomics to investigate cancer heterogeneity, HIV reservoir characterization, and neurological disorders. A recurring theme is the development and application of novel genomic methodologies to address previously intractable biological questions, particularly in the areas of tumor microenvironment analysis, viral persistence mechanisms, and cellular heterogeneity in complex tissues. Dr. Sebra has established significant leadership roles within Mount Sinai's genomic research infrastructure, directing both The Center for Advanced Genomics Technology and the Technology Development arm of the Genomics Core Facility. His work bridges basic genomic technology development with clinical translation, particularly in cancer and infectious disease applications. As evidenced by his extensive publication record, Dr. Sebra collaborates widely across disciplines, contributing genomic expertise to studies ranging from HIV persistence to disc degeneration to cancer immunotherapy. His industry relationship with Panacent Bio, where he serves as Founder/Co-Founder/Partner, further demonstrates his commitment to translating genomic discoveries into practical applications.

Vivek KumarView profile

Associate Professor

• Biomaterials
• Peptide Engineering
• Drug Delivery
• +6 more

Vivek Kumar is an Associate Professor in the Department of Biomedical Engineering at the New Jersey Institute of Technology (NJIT), where he leads research at the intersection of biomolecular engineering, materials science, and synthetic peptide chemistry. His work focuses on developing self-assembling peptide hydrogels for therapeutic applications including drug delivery, tissue regeneration, and disease treatment. His educational foundation includes: B.S. in Biomedical Engineering from Northwestern University (2006) Ph.D. in Bioengineering from Georgia Institute of Technology (2011) Post-doctoral fellowship in Surgery at BIDMC and Wyss Institute, Harvard Medical School (2012) NIH-NRSA Post-doctoral fellowship in Supramolecular Chemistry at Rice University (2016) Dr. Kumar's research specializes in creating tunable peptide-based biomaterials that modulate biological processes like angiogenesis and inflammation. His laboratory develops hierarchically assembled scaffolds for applications ranging from dental pulp regeneration to antiviral therapies and ocular disease treatment. This work bridges fundamental science with translational impact, evidenced by over 50 publications, 70 conference abstracts, and numerous patents. Analysis of his recent publications reveals a strong emphasis on peptide hydrogel platforms for spatiotemporal drug delivery, with significant contributions in ocular therapeutics, cardiovascular repair, and pandemic response. His work demonstrates consistent innovation in tailoring nano-architectured materials for specific biological challenges, particularly in translating bench discoveries to preclinical applications. His scientific recognition includes: American Heart Association Pre-doctoral Fellowship NIDCR NRSA F32 Post-doctoral Fellowship Dr. Kumar maintains robust funding from NIH (NEI R15, NIDCR R01), NSF (STTR, SBIR, I-Corps), New Jersey Health Foundation, and Rutgers TechAdvance. He mentors 5 current PhD students, 1 post-doc, and over 15 undergraduates through NJIT's URI program. As founder and Chairman of biotech startups NangioTx, Inc. and SAPHTx, Inc., he actively translates technologies toward clinical trials. His laboratory operates as an integrated translational hub with equipment for peptide synthesis, biomaterial characterization, and in vivo testing across multiple animal models. Through the Center for Science, Medicine, and Engineering Outreach (CSMEO), he extends impact to high school STEM education across half a dozen schools.

Tone TønjumView profile

Professor

• Microbiology
• Molecular Biology
• Infectious Disease Research
• +4 more

Tone Tønjum is a Professor at the Department of Microbiology , University of Oslo. Her research spans Mycobacterium tuberculosis pathogenesis, antimicrobial resistance , and DNA repair mechanisms in bacterial pathogens. Member of Det Norske Videnskaps-Akademi (The Norwegian Academy of Science and Letters) European Academy of Microbiology Key research areas include: proteomics of drug-resistant tuberculosis, drug development for mycobacterial infections, and DNA metabolism in pathogenic bacteria. Collaborations extend to the Center for Healthy Aging (CEHA) , Copenhagen, and the Institute for Molecular Infection Biology (IMIB) , Würzburg. Recent work explores bioisosteric drug modifications to reduce linezolid toxicity, novel antitubercular hybrids (e.g., spirooxindolopyrrolidine-chromanone), and epiphytic marine biomass as antimicrobial resources. Publications highlight interdisciplinary approaches combining organic synthesis, computational modeling, and clinical microbiology. Scientific awards include membership in the Norwegian Academy of Science and Letters and the European Academy of Microbiology. Her affiliations with research groups like Genome Dynamics and SERTA: Healthy Brain Ageing Centre reflect cross-disciplinary interests, including neurodegenerative disease mechanisms. Contact: tone.tonjum@medisin.uio.no , +47 90152936.